YAKUGAKU ZASSHI - JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, published by the Pharmaceutical Society of Japan, is a key academic journal dedicated to advancing the field of pharmaceutical sciences. Established in 1961 and set to contribute until 2024, this journal publishes original research articles, reviews, and clinical studies that encompass a wide spectrum of topics within pharmacology, toxicology, and pharmaceutics. Although the journal operates under a traditional subscription model, it maintains a recognized reputation with an impact factor that is steadily aligned within its category quartiles—ranking Q3 in Pharmaceutical Science and Q4 in Pharmacology as of 2023. With Scopus rankings reflecting its competitive standing, YAKUGAKU ZASSHI serves as a vital resource for researchers, professionals, and students looking to engage with innovative findings and broaden their understanding of pharmaceutical methodologies and research practices. With a current focus on bridging scientific research with real-world applications, it seeks to foster collaboration and knowledge sharing within the pharmaceutical community.

US PHARMACIST, published by Jobson Publishing LLC, is a key resource in the field of pharmaceutical sciences and pharmacy, with a robust legacy dating back to 1979. The journal, identifiable by the ISSN 0148-4818 and E-ISSN 2331-3501, serves as a platform for sharing insightful research, critical reviews, and advancements that shape the industry and improve patient care. Although categorized in the fourth quartile for several aspects of pharmaceutical science and pharmacology, its targeted focus on pharmacy practice provides a unique perspective that is essential for practitioners and students alike. The journal offers an essential medium for continuous professional development, promoting knowledge dissemination among healthcare professionals. Given its dedication to enhancing pharmaceutical education and practice, it remains a vital tool for those engaged in the science and application of pharmacy. Notably, access options are not open, but subscribers can benefit from the journal's rich content focused on advancing the pharmacy field in the context of contemporary health challenges.

Farmaceuticos Comunitarios, an esteemed open-access journal published by the SOC ESPANOLA FARMACIA FAMILIAR & COMUNITARIA-SEFAC, focuses on advancing the field of community pharmacy and pharmaceutical care. With its inception in 2014 as an open-access journal, it aims to disseminate crucial research findings, case studies, and reviews that contribute to enhancing pharmaceutical services in the community. Based in Madrid, Spain, this journal serves as a platform for researchers, practitioners, and students to explore current trends and best practices within the sphere of pharmacy. Although it currently holds respectable rankings within Scopus, including its position in nursing and pharmacy disciplines, the journal continuously aspires to elevate its impact and relevance in the domain of pharmaceutical sciences. By providing unfettered access to quality research, Farmaceuticos Comunitarios plays a pivotal role in promoting knowledge sharing and improving healthcare outcomes within the community pharmacy sector.

JOURNAL OF PHARMACY TECHNOLOGY is a premier publication in the field of Pharmaceutical Science, established in 1989 and published by SAGE PUBLICATIONS INC. This journal serves as an essential resource for professionals, researchers, and students dedicated to the advancements in pharmacy technology and the application of innovative solutions in pharmaceutical practices. With an ISSN of 8755-1225 and an E-ISSN of 1549-4810, the journal provides a rigorous peer-reviewed platform for disseminating cutting-edge research and case studies. As of 2023, it is ranked Q3 in the Scopus categories of Pharmacology, Toxicology, and Pharmaceutics, highlighting its relevance in the field. Although it currently does not offer an Open Access option, JOURNAL OF PHARMACY TECHNOLOGY aims to remain a critical avenue for scholarly communication and knowledge dissemination among practitioners in the pharmaceutical sector, ensuring they stay informed of the latest trends and findings that impact their work.

The Journal of Managed Care & Specialty Pharmacy is a premier publication in the realm of health policy and pharmaceutical science, dedicated to enhancing the understanding and practices surrounding managed care systems and specialty medications. Published by ACAD MANAGED CARE PHARMACY, this journal boasts an impressive Q1 ranking in both Pharmaceutical Science and Pharmacy, underscoring its significance in advancing professional discourse and research in these critical areas. With a focus on innovative care strategies and patient-centered approaches, it aims to share impactful research, reviews, and opinions that shape the future of health policy and pharmaceutical practices. The journal is available in an open access format, ensuring that vital information is universally accessible to researchers, practitioners, and policymakers alike. With its inception in 2014 and an ongoing commitment to excellence through 2024, the journal is firmly established as a leading resource within its field, making it essential reading for professionals dedicated to improving managed care and specialty pharmacy solutions.

The Journal of Pharmacy and Bioallied Sciences is a premier open access publication that has been contributing to the fields of Pharmacy, Bioengineering, and Biochemistry since its establishment in India, under the esteemed Wolters Kluwer Medknow Publications. With the ISSN 0976-4879 and E-ISSN 0975-7406, this journal provides a platform for high-quality research articles, reviews, and clinical studies aimed at advancing knowledge and practice in the pharmaceutical and allied sciences. As a reflection of its academic stature, the journal holds a respectable categorization within the third and fourth quartiles in pertinent fields according to the latest metrics, with rankings that place it among prominent emerging research in pharmacology and biochemistry. Researchers and professionals are encouraged to access a wealth of knowledge freely, as the journal has been open access since 2010. The journal not only aims to foster innovative research but also strives to bridge the gap between pharmaceutical sciences and real-world applications, making it an essential resource for students, academics, and industry experts alike.

Research in Social & Administrative Pharmacy, published by Elsevier Science Inc, is a premier academic journal that plays a pivotal role in shaping the field of pharmaceutical sciences and pharmacy practice. With an impressive impact factor and ranked in the Q1 category for both Pharmaceutical Science and Pharmacy, this journal is dedicated to the dissemination of cutting-edge research from 2005 to 2024. Targeting a diverse audience of researchers, professionals, and students, the journal covers a broad spectrum of topics including social pharmacy, policy, and administrative aspects of pharmacy practice, contributing to advancements in healthcare. As an essential resource for those engaging in pharmaceutical research, the journal upholds rigorous peer-review standards and ensures wide accessibility to influential studies that address contemporary issues in pharmacy and healthcare administration, making it an invaluable tool for knowledge enhancement and practical applications.

The European Journal of Hospital Pharmacy, published by the prestigious BMJ PUBLISHING GROUP, stands as a vital resource in the field of pharmacy, specifically focused on practices within hospital settings. With its ISSN 2047-9956 and E-ISSN 2047-9964, this journal provides an essential platform for researchers, practitioners, and students to disseminate and access high-quality research that influences clinical practice. Recognized for its significant impact, the journal has achieved a commendable Q2 ranking in both the Pharmacology, Toxicology and Pharmaceutics (miscellaneous) and Pharmacy categories according to Scopus, highlighting its status within the academic community. The journal is indexed among the top 18% in its category, showcasing innovative research and advancements in the field. While the European Journal of Hospital Pharmacy does not operate under an open-access model, its deep commitment to enhancing pharmaceutical care within European hospital settings remains undeterred. The journal also covers a converged period from 2010 to 2024, providing comprehensive insights into evolving practices and challenges. As a premier publication, it plays an essential role in education and professional development, making it indispensable for those involved in pharmacy and healthcare.

Pharmacy is a premier open-access journal published by MDPI, dedicated to advancing research in the dynamic field of pharmaceutical sciences. Since its inception in 2013, this journal has become a vital platform for disseminating novel findings, reviews, and insights related to drug development, pharmacokinetics, pharmaceutical technology, and clinical applications. With an E-ISSN of 2226-4787, Pharmacy prioritizes accessibility and visibility, allowing researchers, professionals, and students from around the globe to engage with cutting-edge research without barriers. The journal plays a crucial role in shaping pharmaceutical education and practice, fostering innovative ideas and collaborative approaches aimed at improving health outcomes. As part of the MDPI family, Pharmacy is committed to maintaining high-quality standards, ensuring that all published articles undergo rigorous peer review.

Welcome to the JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, a prestigious open access journal published by FRONTIERS MEDIA SA since 2008, dedicated to advancing research in the fields of pharmacy and pharmaceutical sciences. With its strong rooting in Canada, this journal has established itself within the academic community by consistently delivering high-quality studies and insights, as evidenced by its respectable Q2 ranking in both Medicine (miscellaneous) and Pharmaceutical Science categories for 2023, along with a notable 77th percentile ranking in Pharmaceutical Science on Scopus. Spanning over two decades of publication from 1998 to 2024, the journal focuses on critical research areas including pharmacology, toxicology, and drug development. By providing open access to its articles, the journal ensures that vital scientific information is readily available to researchers, professionals, and students alike, fostering collaboration and innovation within these essential disciplines. We invite you to explore the latest findings and contribute to the ongoing dialogue in pharmaceutical research through this essential platform.